CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,966,069
- in 2 filings, $18.0M under 10b5-1 plans
Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-14 | Krishnan Krish S President and CEO | Sale 10b5-1 | −13,400 | $150.30 | $2.0M | 1,512,529 |
| 2025-07-14 | Krishnan Krish S President and CEO | Sale 10b5-1 | −13,335 | $150.29 | $2.0M | 1,443,376 |
| 2025-07-14 | Krishnan Krish S President and CEO | Sale 10b5-1 | −100 | $151.00 | $15K | 1,443,276 |
| 2025-07-10 | Krishnan Suma President, R&D | Sale 10b5-1 | −6,500 | $150.23 | $976K | 1,457,011 |
| 2025-07-10 | Krishnan Suma President, R&D | Sale 10b5-1 | −300 | $151.39 | $45K | 1,456,711 |
| 2025-07-10 | Krishnan Suma President, R&D | Sale 10b5-1 | −6,627 | $150.22 | $995K | 1,526,229 |
| 2025-07-10 | Krishnan Suma President, R&D | Sale 10b5-1 | −300 | $151.39 | $45K | 1,525,929 |
| 2025-07-10 | Krishnan Krish S President and CEO | Sale 10b5-1 | −6,627 | $150.22 | $995K | 1,526,229 |
| 2025-07-10 | Krishnan Krish S President and CEO | Sale 10b5-1 | −300 | $151.39 | $45K | 1,525,929 |
| 2025-07-10 | Krishnan Krish S President and CEO | Sale 10b5-1 | −6,500 | $150.23 | $976K | 1,457,011 |
| 2025-07-10 | Krishnan Krish S President and CEO | Sale 10b5-1 | −300 | $151.39 | $45K | 1,456,711 |
| 2025-07-09 | Krishnan Suma President, R&D | Sale 10b5-1 | −200 | $150.14 | $30K | 1,463,511 |
| 2025-07-09 | Krishnan Suma President, R&D | Sale 10b5-1 | −200 | $150.07 | $30K | 1,532,856 |
| 2025-07-09 | Krishnan Krish S President and CEO | Sale 10b5-1 | −200 | $150.07 | $30K | 1,532,856 |
| 2025-07-09 | Krishnan Krish S President and CEO | Sale 10b5-1 | −200 | $150.14 | $30K | 1,463,511 |
| 2025-06-30 | Mazzacco Catherine Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2025-06-30 | Sutherland Everett Rand Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2025-06-30 | Mason Christopher Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2025-06-30 | JANNEY DANIEL Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2025-06-30 | Gangolli Julian S Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 |
Page 12 of 42 · 828 trades